Rockwell Medical (RMTI) Tops Q4 EPS by 7c, Beats on Revenue
Tweet
Share
E-mailGet Alerts RMTI Hot Sheet
Price: $7.99 --0%
Revenue Growth %: +14.9%
Financial Fact:
Net Income (Loss): -4.56M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Revenue Growth %: +14.9%
Financial Fact:
Net Income (Loss): -4.56M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Rockwell Medical (NASDAQ: RMTI) reported Q4 EPS of $0.02, $0.07 better than the analyst estimate of ($0.05). Revenue for the quarter came in at $18.3 million versus the consensus estimate of $16.53 million.
For earnings history and earnings-related data on Rockwell Medical (RMTI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Concurrent Technologies (CNC:LN) PT Raised to GBP3.20 at Berenberg
- Micropolis Robotics displays autonomous robots at Dubai investment event
- Alpha Compute reports $1.57M monthly cash flow and $1.5B pipeline
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
